Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098421
Filing Date
2024-11-14
Accepted
2024-11-14 16:05:56
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0221003-10q_incannex.htm   iXBRL 10-Q 426912
2 CERTIFICATION ea022100301ex31-1_incannex.htm EX-31.1 11095
3 CERTIFICATION ea022100301ex31-2_incannex.htm EX-31.2 10894
4 CERTIFICATION ea022100301ex32-1_incannex.htm EX-32.1 4253
5 CERTIFICATION ea022100301ex32-2_incannex.htm EX-32.2 4531
  Complete submission text file 0001213900-24-098421.txt   3279854

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ixhl-20240930.xsd EX-101.SCH 38202
7 XBRL CALCULATION FILE ixhl-20240930_cal.xml EX-101.CAL 29731
8 XBRL DEFINITION FILE ixhl-20240930_def.xml EX-101.DEF 157968
9 XBRL LABEL FILE ixhl-20240930_lab.xml EX-101.LAB 301054
10 XBRL PRESENTATION FILE ixhl-20240930_pre.xml EX-101.PRE 166467
71 EXTRACTED XBRL INSTANCE DOCUMENT ea0221003-10q_incannex_htm.xml XML 255573
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41106 | Film No.: 241461944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)